In last trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 1.31 million shares changing hands with its beta currently measuring -0.03. Company’s recent per share price
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) has a beta value of -0.01 and has seen 20.87 million shares traded in the recent trading session. The company, currently
In the last trading session, 2.59 million shares of the Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) were traded, and its beta was -0.00. Most recently the company’s
In last trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 0.47 million shares changing hands with its beta currently measuring 0.10. Company’s recent per share price
During the last session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares were 1.73 million, with the beta value of the company hitting 0.25. At the end
In the last trading session, 2.29 million shares of the Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) were traded, and its beta was 0.25. Most recently the company’s
Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)’s traded shares stood at 4.0 million during the last session, with the company’s beta value hitting 0.21. At the close of
In the last trading session, 7.33 million Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) shares changed hands as the company’s beta touched 0.28. With the company’s per share
In recent trading session, Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) saw 0.49 million shares changing hands at last check today with its beta currently measuring 0.25. Company’s
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne